1. Long-Term Treatment With EPO Increases Serum Levels of High-Density Lipoprotein in Patients With CKD 
Kostas C. Siamopoulos, MD, FRSH, Chariklia Gouva, MD, Konstantinos P. Katopodis, MD, Christos Tzallas, Peter Nikolopoulos, Eleni C. Papavasiliou, MSc, Alexandros D. Tselepis, MD, PhD 
American Journal of Kidney Diseases 
Volume 48, Issue 2, Pages (August 2006)
DOI: /j.ajkd
Copyright © 2006 National Kidney Foundation, Inc. Terms and Conditions

2. Fig 1
Bar graph shows serum HDL-C levels in patients with CKD during follow-up. To convert HDL-C in mg/dL to mmol/L, multiply by
American Journal of Kidney Diseases  , DOI: ( /j.ajkd )
Copyright © 2006 National Kidney Foundation, Inc. Terms and Conditions

3. Fig 2
Correlation between increase in hemoglobin (Hb) levels and increase in HDL-C levels in patients with CKD treated with EPO.
American Journal of Kidney Diseases  , DOI: ( /j.ajkd )
Copyright © 2006 National Kidney Foundation, Inc. Terms and Conditions